2017 Press Releases

MADRID , Oct. 13, 2015 /PRNewswire/ -- (Booth #4G30) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative systems and component solutions for injectable drug administration, today launched Daikyo RUV® (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe

EXTON, Pa. , Sept. 30, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Annette Favorite to serve as Senior Vice President and Chief Human Resources Officer, effective

Connected health leaders complete first two phases of medication adherence collaboration EXTON, Pa. , Sept. 17, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC , today announced the completion of the first two phases of their four-phase

Reduces Pension Obligation by 44% EXTON, PA -- ( Marketwired ) -- 09/10/15 -- West Pharmaceutical Services, Inc. ("West") (NYSE: WST) today announced that it has entered into an agreement to purchase a group life annuity contract from Metropolitan Life Insurance Company ( MetLife ) to settle

EXTON, PA -- ( Marketwired ) -- 09/02/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: CL King's

Delivers Sales of $359.7 Million and Adjusted Diluted EPS of $0.47. Raises Lower-End of Full-Year 2015 Adjusted Diluted EPS to a New Range of $1.74 to $1.84 -- Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 07/30/15 -- West Pharmaceutical Services, Inc.

EXTON, PA -- ( Marketwired ) -- 07/23/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release second quarter 2015 financial results before the market opens on Thursday, July 30, 2015 , and will follow with a conference call to discuss the results and business

Patient-friendly wearable injector utilized in multiple active drug development programs EXTON, Pa. , July 20, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it has

EXTON, PA -- ( Marketwired ) -- 07/14/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a fourth-quarter 2015 dividend of $0.12 per share, a 9.1% increase over the $0.11 per share declared for each of the four preceding quarters.

EXTON, PA -- ( Marketwired ) -- 07/01/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company will pay a third-quarter 2015 dividend of $0.11 per share. The dividend will be paid on August 5, 2015 to shareholders of record as of July 22, 2015 .

Deepens investment in Ireland to support growing global customer demand WATERFORD, Ireland , June 16, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, hosted a groundbreaking ceremony in Waterford,

EXTON, PA -- ( Marketwired ) -- 05/27/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at Jefferies 2015 Healthcare Conference, New York, NY at 10:30 a.m. ET on Wednesday, June 3 rd , 2015.

EXTON, Pa. , May 12, 2015 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, today announced a multi-year investment as part of the Company's evolving research and development strategy.

EXTON, PA -- ( Marketwired ) -- 05/06/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at each of the following conferences: Bank of America Merrill Lynch 2015 Global Health Care Conference , Las

Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 04/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2015 and updated financial guidance for the full year 2015.

EXTON, PA -- ( Marketwired ) -- 04/23/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release first quarter 2015 financial results before the market opens on Thursday, April 30, 2015 , and will follow with a conference call to discuss the results and business

EXTON, PA -- ( Marketwired ) -- 04/15/15 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Eric M. Green has been appointed the company's Chief Executive Officer, succeeding Donald E. Morel, Jr.

EXTON, PA -- ( Marketwired ) -- 03/05/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the Barclays Global Healthcare Conference , Miami, FL at 2:05 p.m. ET on Thursday, March 12 th , 2015.

EXTON, PA -- ( Marketwired ) -- 02/20/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2015 dividend of $0.11 per share. The dividend will be paid on May 6, 2015 to shareholders of record as of April 22, 2015 .

Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 02/19/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year 2014 and provided annual financial guidance for 2015.

EXTON, PA -- ( Marketwired ) -- 02/12/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2014 financial results before the market opens on Thursday, February 19, 2015 and will follow with a conference call to discuss the results

Sterile, ready-to-use drug vial seals help pharmaceutical and biopharmaceutical manufacturers meet regulatory challenges and ensure drug safety EXTON, Pa. , Feb. 11, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug

EXTON, PA -- ( Marketwired ) -- 01/09/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business and outlook at the 33 rd Annual J.P. Morgan Healthcare Conference , San Francisco, CA at 8:00 a.m.

EXTON, PA -- ( Marketwired ) -- 12/22/14 -- In the news release issued Friday, December 19, 2014 by West Pharmaceutical Services, Inc. (NYSE: WST), we are advised by the company that the originally issued headline was incorrect. Complete corrected text follows.

EXTON, PA -- ( Marketwired ) -- 12/19/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2015 dividend of $0.11 per share. The dividend will be paid on February 4, 2015 to shareholders of record as of January 21,

EXTON, PA -- ( Marketwired ) -- 12/01/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced the automatic conversion of the 4% convertible junior subordinated debentures due March 15, 2047 ("Debentures") that remain outstanding on December 9, 2014 ("Conversion Date").

Staked-needle prefillable syringe safety system helps reduce risk of needlestick injury to healthcare workers and patients EXTON, Pa. , Nov. 11, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today

Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 10/30/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2014 and updated its revenue and gross margin guidance for 2014 and its long-term financial

EXTON, PA -- ( Marketwired ) -- 10/23/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 30, 2014 and will follow with a conference call to discuss the results and business expectations at

Universal needle-free reconstitution and transfer system now available for use in hospitals EXTON, Pa. , Oct. 21, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the

Chairman and CEO Donald E. Morel, Jr. to Retire at 2015 Annual Meeting Company Commences Search for Successor; Updates 2014 Outlook EXTON, Pa. , Oct. 15, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems,

EXTON, Pa. , Oct. 7, 2014 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is a global business unit within West, and is the company's largest, generating

Collaboration designed to improve and reward medication adherence EXTON, Pa. , Oct. 6, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service (SaaS) medication

Expands global capabilities to meet customer demand WATERFORD, Ireland , Oct. 2, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today it plans to expand its global manufacturing operations

EXTON, PA -- ( Marketwired ) -- 09/02/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: CL King's

Conference Call Scheduled for 9 a.m. Today EXTON, PA -- ( Marketwired ) -- 07/31/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2014 and updated its revenue and gross margin guidance for the year.

EXTON, Pa. , July 24, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss the results and business

EXTON, PA -- ( Marketwired ) -- 07/16/14 -- In the news release, "West Announces 10% Increase in Quarterly Dividend," issued earlier today by West Pharmaceutical Services Inc. (NYSE: WST), we are advised by the company that the last sentence of the first paragraph should read "The fourth-quarter

EXTON, PA -- ( Marketwired ) -- 07/16/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a fourth-quarter 2014 dividend of $0.11 per share, a 10% increase over the $0.10 per share declared for each of the four preceding quarters.

Expands Presence in Asia Markets CHENNAI, India , July 16, 2014 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary packaging for injectable medicines